ReWalk’s soft suit completes trials

I reported previously (see here) about ReStore, the soft suit exoskeleton from Israel’s ReWalk that enables stroke patients to walk. ReStore recently completed successful trials at five US rehabilitation centers and ReWalk has now applied for US FDA and European CE approval.,7340,L-3756695,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *